Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
Outlook Therapeutics(OTLK) MarketBeat·2024-06-19 19:38
Outlook Therapeutics NASDAQ: OTLK has gained attention, with analysts forecasting an upside of over 500% based on the consensus price target. Outlook Therapeutics Today OTLK Outlook Therapeutics 4.00 ▼ 46.43 Add to Watchlist It's essential to remember that low-float biopharmaceutical companies often experience volatility due to frequent breaking news and technical factors such as float size and short interest. While the bullish price target is notewor ...